Limited Competition: Revision for Resuscitation Outcomes Center Randomized Clinical Trial (U01)

Post Date

March 2nd 2011

Application Due Date

May 3rd 2011

Funding Opportunity Number

RFA-HL-11-036

CFDA Number(s)

93.837

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Eligibility Categories

Other

Other Eligible Applicants include the following: Only the currently funded NHLBI Resuscitation Outcomes Centers are eligible to apply.

Funding

• Award Range:

  $None - $None

Grant Description

The National Heart, Lung, and Blood Institute (NHLBI) invites research grant applications for a Revision award (formerly referred to as a competing supplement) for the Resuscitation Outcomes Consortium (RFA-HL-10-006) to conduct a multi-center, randomized, phase III trial that will test acute survival benefits of increased plasma: platelets: RBCs ratio (1:1:1) compared to 1:1:higher ratio (1:1:2 or 1:1:3), among patients predicted to receive massive blood transfusions.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-11-036.html